Pharmaceutical targeting cancer stem cells in breast cancer
Reference number | |
Coordinator | Cormorant Pharmaceuticals AB |
Funding from Vinnova | SEK 15 538 |
Project duration | February 2013 - May 2013 |
Status | Completed |
Your browser doesn't support javascript. This means that the content or functionality of our website will be limited or unavailable. If you need more information about Vinnova, please contact us.
You're using version {0} of the web browser {1}. This means that the content or functionality of our website may be limited or unavailable. We recommend that you upgrade your browser to optimise your experience of our website.
Pharmaceutical targeting cancer stem cells in breast cancer
Reference number | 2013-01091 |
Coordinator | Cormorant Pharmaceuticals AB |
Funding from Vinnova | SEK 15 538 |
Project duration | February 2013 - May 2013 |
Status | Completed |
Last updated 25 November 2019
Reference number 2013-01091